Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii

Journal of Neurosciences in Rural Practice

Volumn 7, Issue 3, 2016, Pages 450-452

  Shrestha, Gentle Sunder ^a   Tamang, Sushil ^a   Paneru, Hem Raj ^a   Shrestha, Pramesh Sunder ^a   Keyal, Niraj ^a   Acharya, Subhash Prasad ^a   Marhatta, Moda Nath ^a   Shilpakar, Sushil ^a  

^a TRIBHUVAN UNIVERSITY TEACHING HOSPITAL   (Nepal)

Author keywords

Acinetobacter baumannii; colistin; intraventricular; multidrug resistant; tigecycline; ventriculitis

Indexed keywords

CEFTAZIDIME; CEFTRIAXONE; COLISTIN; CREATININE; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; BACTERIUM CULTURE; BRAIN CONTUSION; BRAIN VENTRICULITIS; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEVER; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRACRANIAL PRESSURE; LOADING DRUG DOSE; MALE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUPIL REFLEX; RESPIRATORY TRACT INTUBATION; SUBDURAL HEMATOMA; VENTRICULOSTOMY CATHETER;

EID: 84973450824     PISSN: 09763147     EISSN: 09763155     Source Type: Journal    
DOI: 10.4103/0976-3147.176194     Document Type: Article

References (10)

1. Brain Trauma Foundation, American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), AANS/CNS Joint Section on Neurotrauma and Critical Care. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma 2007;24 Suppl 1:S45-54.
2. Bargiacchi O, Rossati A, Car P, Brustia D, Brondolo R, Rosa F, et al. Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: Case reports and review. Infection 2014;42:801-9.
3. Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, et al. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 2010;14:e572-9.
4. Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009;9:245-55.
5. Katragkou A, Roilides E. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol 2005;43:4916-7.
6. Gordon NC, Wareham DW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother 2009;63:775-80.
7. Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14.
8. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
9. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84.
10. Chatzi M, Karvouniaris M, Makris D, Tsimitrea E, Gatos C, Tasiou A, et al. Bundle of measures for external cerebral ventricular drainage-associated ventriculitis. Crit Care Med 2014;42:66-73.